Permeability of the blood-brain barrier in psychiatric patients - PubMed (original) (raw)
Permeability of the blood-brain barrier in psychiatric patients
E F Torrey et al. Am J Psychiatry. 1985 May.
No abstract available
Similar articles
- Blood-cerebrospinal fluid barrier in schizophrenic patients.
Bauer K, Kornhuber J. Bauer K, et al. Eur Arch Psychiatry Neurol Sci. 1987;236(5):257-9. doi: 10.1007/BF00380949. Eur Arch Psychiatry Neurol Sci. 1987. PMID: 3653145 - Principles of albumin and IgG analyses in neurological disorders. II. Relation of the concentration of the proteins in serum and cerebrospinal fluid.
Link H, Tibbling G. Link H, et al. Scand J Clin Lab Invest. 1977 Sep;37(5):391-6. doi: 10.1080/00365517709091497. Scand J Clin Lab Invest. 1977. PMID: 337460 Clinical Trial. No abstract available. - Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.
Tibbling G, Link H, Ohman S. Tibbling G, et al. Scand J Clin Lab Invest. 1977 Sep;37(5):385-90. doi: 10.1080/00365517709091496. Scand J Clin Lab Invest. 1977. PMID: 337459 Clinical Trial. No abstract available. - [Origin of the proteins and cells of the cerebrospinal fluid. (Review of the literature)].
Murzaliev AM. Murzaliev AM. Sov Zdravookhr Kirg. 1972 May-Jun;3:7-12. Sov Zdravookhr Kirg. 1972. PMID: 4125533 Review. Russian. No abstract available. - CLINICAL ASPECTS OF THE BLOOD-BRAIN BARRIER.
BARLOW CF. BARLOW CF. Annu Rev Med. 1964;15:187-202. doi: 10.1146/annurev.me.15.020164.001155. Annu Rev Med. 1964. PMID: 14133843 Review. No abstract available.
Cited by
- Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis.
Orlovska-Waast S, Köhler-Forsberg O, Brix SW, Nordentoft M, Kondziella D, Krogh J, Benros ME. Orlovska-Waast S, et al. Mol Psychiatry. 2019 Jun;24(6):869-887. doi: 10.1038/s41380-018-0220-4. Epub 2018 Aug 16. Mol Psychiatry. 2019. PMID: 30116031 Free PMC article. - Antigliadin Antibodies (AGA IgG) Are Related to Neurochemistry in Schizophrenia.
Rowland LM, Demyanovich HK, Wijtenburg SA, Eaton WW, Rodriguez K, Gaston F, Cihakova D, Talor MV, Liu F, McMahon RR, Hong LE, Kelly DL. Rowland LM, et al. Front Psychiatry. 2017 Jun 19;8:104. doi: 10.3389/fpsyt.2017.00104. eCollection 2017. Front Psychiatry. 2017. PMID: 28674504 Free PMC article. - Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand?
Vasic N, Connemann BJ, Wolf RC, Tumani H, Brettschneider J. Vasic N, et al. Eur Arch Psychiatry Clin Neurosci. 2012 Aug;262(5):375-91. doi: 10.1007/s00406-011-0280-9. Epub 2011 Dec 16. Eur Arch Psychiatry Clin Neurosci. 2012. PMID: 22173848 Review. - Viruses, schizophrenia, and bipolar disorder.
Yolken RH, Torrey EF. Yolken RH, et al. Clin Microbiol Rev. 1995 Jan;8(1):131-45. doi: 10.1128/CMR.8.1.131. Clin Microbiol Rev. 1995. PMID: 7704891 Free PMC article. Review. - Failure to detect dopamine receptor IgG autoantibodies in sera of schizophrenic patients. Short note.
von Kirchbach A, Fischer EG, Kornhuber HH. von Kirchbach A, et al. J Neural Transm. 1987;70(1-2):175-9. doi: 10.1007/BF01252518. J Neural Transm. 1987. PMID: 3668519
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical